SCHEMBL19471844

SCHEMBL19471844

CN1CCC(Oc2cncc(-c3cncc(C=O)c3)n2)C1

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 6/20 0.42
▸ ATM Q13315 1/20 0.35
▸ ATR Q13535 1/20 0.35
▸ TLR7 Q9NYK1 2/20 0.34
▸ CNR2 P34972 1/20 0.32
▸ CHEK2 O96017 1/20 0.32
▸ MET P08581 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17687832 1.00 FFAR4 (0.42) FFAR4ATMATRTLR7CNR2
SCHEMBL17687824 0.92 FFAR4 (0.38) FFAR4TLR7
SCHEMBL17687792 0.88 BTK (0.41) FFAR4
SCHEMBL19471678 0.82 FFAR4 (0.39) FFAR4ATMATRTLR7CNR2
SCHEMBL17687807 0.82 FFAR4 (0.39) FFAR4ATMATRTLR7CNR2
SCHEMBL19471735 0.81 FFAR4 (0.40) FFAR4ATMATRMET
SCHEMBL17687786 0.81 FFAR4 (0.40) FFAR4ATMATRMET
SCHEMBL19471587 0.76 BTK (0.40) FFAR4ATMATRMET
SCHEMBL17687794 0.76 BTK (0.40) FFAR4ATMATRMET
SCHEMBL19471785 0.75 FFAR4 (0.44) FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3207042-B1 ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION IDORSIA PHARMACEUTICALS LTD (CH) 2018-10-03 — — EP disclosed
US-9850256-B2 Antibacterial basic biaromatic derivatives with aminoalkoxy substitution IDORSIA PHARMACEUTICALS LTD (CH) 2017-12-26 — — US disclosed
US-20170305927-A1 ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION IDORSIA PHARMACEUTICALS LTD (CH) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305927-A1 ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION RPSA, RPL4, RPS4Y1 FFAR4 912/4885ATM 2857/4885ATR 2777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback